Tranquility Ketamine: The Benefits of Being an Osmind Clinic

/in ,

At our clinic, evidence-based care is at the heart of every treatment plan. The clinic’s commitment to innovation and measurable outcomes is exemplified by its integration of Osmind, a cutting-edge technology platform that optimizes mental health treatments such as Ketamine Infusion Therapy.

As one of the nation’s leading platforms for interventional psychiatry, Osmind empowers clinics and their patients with real-world data, automated progress tracking, and research-backed insights — transforming the way treatment success is measured and understood.

What Is Osmind?

Osmind is a specialized electronic health record (EHR) and outcomes tracking system built specifically for advanced mental health treatments such as ketamine infusion therapy (KIT), Spravato, and transcranial magnetic stimulation (TMS).

Unlike traditional EHR systems, Osmind is designed to go beyond documentation. It incorporates measurement-based care — an evidence-driven approach that uses validated psychiatric rating scales and patient-reported outcomes to guide and personalize treatment decisions.

The platform also connects participating clinics into a real-world data network that powers some of the largest published analyses of ketamine’s effectiveness in community practice. This collaboration between clinics, researchers, and data scientists has created an unprecedented evidence base for modern psychiatric treatments.

Real-World Results: The Data Behind Ketamine Efficacy

One of the key strengths of Osmind is its ability to aggregate real-world evidence — data derived from actual patients treated in clinical practice rather than in controlled research trials.

In Osmind’s ORKA-1 study, published in the Journal of Affective Disorders, researchers analyzed the outcomes of 537 patients with depression who received ketamine infusion therapy across 178 community clinics. The findings provide some of the most compelling data to date on ketamine’s impact in real-world settings:

  • After a standard induction series (typically six infusions over 2–3 weeks), approximately 54% of patients responded to treatment, and nearly 30% achieved remission within a month of starting therapy.

  • Among patients who presented with suicidal ideation, more than 70% experienced a reduction in suicidal thoughts, and over 40% no longer reported suicidal ideation following the initial infusion series.

  • In a separate analysis of patients with post-traumatic stress disorder (PTSD), symptom scores decreased by an average of 18–19 points on the PCL-5 scale — a statistically and clinically significant improvement.

These findings demonstrate what many patients and clinicians have observed anecdotally for years: when administered under medical supervision and tracked with consistent data collection, ketamine therapy can deliver rapid, meaningful relief from treatment-resistant depression, anxiety, and trauma-related conditions.

The Advantages of Being an Osmind Clinic

By adopting the Osmind platform, Tranquility Ketamine has enhanced every stage of the treatment process — from patient assessment and safety monitoring to long-term care planning and research participation.

1. Data-Driven Personalization

Osmind automates the collection of validated psychiatric assessments, including the PHQ-9 for depression, the GAD-7 for anxiety, and the PCL-5 for PTSD. This continuous measurement enables clinicians at Tranquility Ketamine to objectively track each patient’s response to treatment and fine-tune dosage, frequency, and maintenance plans.

Clinics that practice measurement-based care consistently report improved treatment outcomes, as decisions are guided by quantifiable progress rather than subjective impressions.

2. Proactive Patient Safety

Osmind’s monitoring tools allow early identification of patients who may be worsening or showing new signs of distress. This rapid feedback loop enables clinicians to intervene quickly — adjusting treatment protocols or offering additional support when necessary.

In a therapy as fast-acting as ketamine, timely awareness can make a life-saving difference.

3. Optimized Maintenance and Durability of Results

Research from Osmind’s database shows that patients who respond to ketamine often maintain benefits for several weeks or months after induction, with about 80% maintaining response at four weeks and around 60% at eight weeks without maintenance infusions.

By combining this data with each patient’s ongoing progress reports, Tranquility Ketamine is able to design customized maintenance schedules, ensuring continued stability and maximizing the long-term benefits of treatment.

4. Enhanced Communication with Providers and Payers

Clear, data-backed documentation of treatment outcomes is invaluable for collaboration with referring psychiatrists, primary care providers, and — when applicable — insurance carriers. Osmind’s reporting features generate professional, exportable summaries of patient progress, facilitating informed care coordination and medical necessity documentation.

5. Improved Patient Engagement

Through Osmind’s patient app, individuals receiving care can log mood data, track symptoms, and record reflections between sessions. This promotes active participation in the healing process and supports integration — the reflective, therapeutic work that helps translate ketamine’s neurobiological changes into lasting emotional growth.

When patients can visualize their own progress, engagement and adherence naturally increase.

6. Contribution to Scientific Progress

Because Osmind aggregates anonymized data from participating clinics nationwide, Tranquility Ketamine contributes to a rapidly expanding pool of real-world evidence on interventional mental health treatments.

This collective data helps researchers refine clinical guidelines, improves safety standards, and accelerates the understanding of how to best use ketamine therapy for conditions like treatment-resistant depression, PTSD, and chronic anxiety.

The Result: More Reliable and Measurable Healing

The integration of Osmind technology ensures that the care patients receive at Tranquility Ketamine is both personalized and evidence-based. Each treatment is informed by live outcome data, which allows for immediate adjustments and continuous optimization.

For patients, this translates to a higher likelihood of relief, improved safety, and a clear view of progress over time. For clinicians, it provides an invaluable feedback mechanism to deliver the most effective and compassionate care possible.

Setting a Higher Standard for Ketamine Therapy

As ketamine infusion therapy continues to evolve, data-driven platforms like Osmind are setting a new standard for accountability and transparency in mental health treatment. By combining compassionate care with measurable science, Tranquility Ketamine ensures that every decision — from dosage adjustments to maintenance planning — is guided by both clinical expertise and real-world evidence.

The result is a model of care that is safer, smarter, and more attuned to the individual. For patients seeking meaningful, measurable relief from depression, anxiety, PTSD, and related conditions, the partnership between Tranquility Ketamine and Osmind represents the future of interventional mental health.

To schedule a consultation or appointment at Tranquility Ketamine, click here.

Sources:

  • Osmind ORKA-1 Study, Journal of Affective Disorders (2022).

  • Osmind Clinical Outcomes Reports and Real-World Data Summaries (2023–2024).

  • Tranquility Ketamine internal data and clinical outcomes tracking (2024).